Despite the remarkable results of leptin-based therapy on weight loss in genetically predisposed obese subjects (mutations in the leptin gene), this approach has a limited or completely absent effect on weight loss in subjects with common obesity, especially in hyperleptinemic patients (3, 152). The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.